Impact of bacterial and viral coinfection in community-acquired pneumonia in adults

Yong Kwan Lim, Oh Joo Kweon, Hye Ryoun Kim, Tae-Hyoung Kim, Mi-Kyung Lee, Yong Kwan Lim, Oh Joo Kweon, Hye Ryoun Kim, Tae-Hyoung Kim, Mi-Kyung Lee

Abstract

Bacterial and viral coinfected community-acquired pneumonia (CAP) is poorly characterized in adults. The aim of this study was to investigate the influence of bacterial and viral coinfection in patients with CAP. A total of 235 adults who requested molecular tests of pneumonia and were diagnosed with CAP were enrolled in this study. Microbiological tests included blood and sputum cultures, PCR for bacterial and viral pathogens, antigen test for Streptococcus pneumoniae and the influenza virus, and antibody detection of Mycoplasma pneumonia. Of the 235 patients, 32 (13.6%) patients were coinfected with bacteria and virus. Among 64 severe CAP patients, the concurrent infections were confirmed in 14 patients (21.9%). The proportion of severe pneumonia was significantly higher in patients with coinfection, and they showed a significantly higher mortality rate. In conclusion, bacterial and viral coinfection in CAP is not a rare occurrence in adults. Viral and bacterial coinfections have an adverse impact on the severity of the pneumonia, and increase morbidity and mortality in patients with CAP.

Keywords: Bacteria; Coinfection; Community-acquired pneumonia; Mortality; Severe pneumonia; Virus.

Copyright © 2018 Elsevier Inc. All rights reserved.

References

    1. ATS, IDSA Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388–416.
    1. Bosch A.A., Biesbroek G., Trzcinski K., Sanders E.A., Bogaert D. Viral and bacterial interactions in the upper respiratory tract. PLoS Pathog. 2013;9(1)
    1. Cawcutt K., Kalil A.C. Pneumonia with bacterial and viral coinfection. Curr Opin Crit Care. 2017;23(5):385–390.
    1. Chertow D.S., Memoli M.J. Bacterial coinfection in influenza: a grand rounds review. JAMA. 2013;309(3):275–282.
    1. Chiu C.Y., Chen C.J., Wong K.S., Tsai M.H., Chiu C.H., Huang Y.C. Impact of bacterial and viral coinfection on mycoplasmal pneumonia in childhood community-acquired pneumonia. J Microbiol Immunol Infect. 2015;48(1):51–56.
    1. Cilloniz C., Ewig S., Polverino E., Marcos M.A., Esquinas C., Gabarrus A. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax. 2011;66(4):340–346.
    1. Fine M.J., Auble T.E., Yealy D.M., Hanusa B.H., Weissfeld L.A., Singer D.E. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243–250.
    1. Huijskens E.G., van Erkel A.J., Palmen F.M., Buiting A.G., Kluytmans J.A., Rossen J.W. Viral and bacterial aetiology of community-acquired pneumonia in adults. Influenza Other Respir Viruses. 2013;7(4):567–573.
    1. Jennings L.C., Anderson T.P., Beynon K.A., Chua A., Laing R.T., Werno A.M. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax. 2008;63(1):42–48.
    1. Karhu J., Ala-Kokko T.I., Vuorinen T., Ohtonen P., Syrjala H. Lower respiratory tract virus findings in mechanically ventilated patients with severe community-acquired pneumonia. Clin Infect Dis. 2014;59(1):62–70.
    1. Klein E.Y., Monteforte B., Gupta A., Jiang W., May L., Hsieh Y.H. The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis. Influenza Other Respir Viruses. 2016;10(5):394–403.
    1. Lieberman D., Shimoni A., Shemer-Avni Y., Keren-Naos A., Shtainberg R., Lieberman D. Respiratory viruses in adults with community-acquired pneumonia. Chest. 2010;138(4):811–816.
    1. Lim W.S., Baudouin S.V., George R.C., Hill A.T., Jamieson C., Le Jeune I. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64(Suppl. 3):iii1–55.
    1. Lim W.S., van der Eerden M.M., Laing R., Boersma W.G., Karalus N., Town G.I. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377–382.
    1. Mandell L.A., Wunderink R.G., Anzueto A., Bartlett J.G., Campbell G.D., Dean N.C. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl. 2):S27–S72.
    1. Martin-Loeches I., M J.S., Vincent J.L., Alvarez-Lerma F., Bos L.D., Sole-Violan J. Increased incidence of co-infection in critically ill patients with influenza. Intensive Care Med. 2017;43(1):48–58.
    1. McCullers J.A. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev. 2006;19(3):571–582.
    1. Morris D.E., Cleary D.W., Clarke S.C. Secondary bacterial infections associated with influenza pandemics. Front Microbiol. 2017;8:1041.
    1. Peto L., Nadjm B., Horby P., Ngan T.T., van Doorn R., Van Kinh N. The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review. Trans R Soc Trop Med Hyg. 2014;108(6):326–337.
    1. Templeton K.E., Scheltinga S.A., van den Eeden W.C., Graffelman A.W., van den Broek P.J., Claas E.C. Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41(3):345–351.
    1. Voiriot G., Visseaux B., Cohen J., Nguyen L.B., Neuville M., Morbieu C. Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia. Crit Care. 2016;20(1):375.
    1. Welte T., Torres A., Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax. 2012;67(1):71–79.
    1. Wiemken T., Peyrani P., Bryant K., Kelley R.R., Summersgill J., Arnold F. Incidence of respiratory viruses in patients with community-acquired pneumonia admitted to the intensive care unit: results from the severe influenza pneumonia surveillance (SIPS) project. Eur J Clin Microbiol Infect Dis. 2013;32(5):705–710.
    1. World Health Organization (WHO) World Health Organization, The top 10 causes of death. 2017. [Available from:
    1. Wunderink R.G., Waterer G.W. Community-acquired pneumonia. N Engl J Med. 2014;370(19):1863.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel